Literature DB >> 16893930

Non-traumatic rhabdomyolysis: the emerging role of CYP 3A4 in diabetes mellitus.

George I Varughese, John H B Scarpello.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16893930      PMCID： PMC1533526          DOI： 10.1177/014107680609900808

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  5 in total

1.  Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease.

Authors:  Mohammad-Reza Movahed; Mehrtash Hashemzadeh; M Mazen Jamal
Journal:  Int J Cardiol       Date:  2005-12-07       Impact factor: 4.164

Review 2.  Statin safety: a systematic review.

Authors:  Malcolm Law; Alicja R Rudnicka
Journal:  Am J Cardiol       Date:  2006-02-03       Impact factor: 2.778

3.  Simvastatin-amiodarone interaction resulting in rhabdomyolysis, azotemia, and possible hepatotoxicity.

Authors:  Basma Ricaurte; Amir Guirguis; Harris C Taylor; Don Zabriskie
Journal:  Ann Pharmacother       Date:  2006-03-14       Impact factor: 3.154

4.  Rhabdomyolysis in association with simvastatin and amiodarone.

Authors:  Laurent Roten; Ronald A Schoenenberger; Stephan Krähenbühl; Raymond G Schlienger
Journal:  Ann Pharmacother       Date:  2004-04-06       Impact factor: 3.154

5.  Nontraumatic rhabdomyolysis: an unusual complication of diabetic hyperosmolar nonketotic (HONK) state.

Authors:  K K Gangopadhyay; R E J Ryder
Journal:  J R Soc Med       Date:  2006-04       Impact factor: 18.000
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.